Inflamed but not impulsive: Acute inflammatory cytokine response does not impact prepotent response inhibition.


Journal

Journal of affective disorders
ISSN: 1573-2517
Titre abrégé: J Affect Disord
Pays: Netherlands
ID NLM: 7906073

Informations de publication

Date de publication:
01 12 2023
Historique:
received: 02 05 2023
revised: 27 08 2023
accepted: 05 09 2023
pmc-release: 01 12 2024
medline: 4 10 2023
pubmed: 9 9 2023
entrez: 8 9 2023
Statut: ppublish

Résumé

Prior evidence has linked inflammation with impulsivity, but most of this evidence is cross-sectional. In this study, we provoked an acute inflammatory cytokine response to see whether it lowered prepotent response inhibition on three cognitive tasks. This study features secondary analyses from a randomized crossover trial in which 171 postmenopausal breast cancer survivors (Stage I-IIIA) each received a typhoid capsular polysaccharide vaccination and a saline placebo injection in a random sequence at two separate visits at least one month apart. Participants completed the Stroop Color-Discrepant Task, the 2-back, and the Conners Continuous Performance Test (CPT) on the computer between 5 and 7 h after the injections. They had their blood drawn once before and repeatedly after the injection to measure interleukin-1 receptor antagonist and interleukin-6 responses. Women committed marginally fewer errors on the Stroop color-discrepant trials after the typhoid vaccine (M = 0.36, SE = 0.08), compared to placebo (M = 0.54, SE = 0.09, p = .076). Injection type did not predict 2-back accuracy (p = .80) or CPT commission errors (p = .47). Inflammatory cytokine responses were also unrelated to the outcomes of interest (ps>.16). We found no evidence that an acute inflammatory cytokine response provokes response disinhibition - an important facet of impulsivity. In fact, our only marginally non-significant result suggested that women were better able to inhibit their prepotent responses on the Stroop after receiving the typhoid vaccine, compared to placebo. Further experimental tests of the acute inflammatory cytokine response's effect on other aspects of impulsivity are warranted. The sample was female, primarily White, highly educated cancer survivors, and recruitment was not premised on impulsive traits or diagnosis with an impulsive-related disorder. Also, there are many facets of impulsivity, and this study only measured response inhibition.

Sections du résumé

BACKGROUND
Prior evidence has linked inflammation with impulsivity, but most of this evidence is cross-sectional. In this study, we provoked an acute inflammatory cytokine response to see whether it lowered prepotent response inhibition on three cognitive tasks.
METHOD
This study features secondary analyses from a randomized crossover trial in which 171 postmenopausal breast cancer survivors (Stage I-IIIA) each received a typhoid capsular polysaccharide vaccination and a saline placebo injection in a random sequence at two separate visits at least one month apart. Participants completed the Stroop Color-Discrepant Task, the 2-back, and the Conners Continuous Performance Test (CPT) on the computer between 5 and 7 h after the injections. They had their blood drawn once before and repeatedly after the injection to measure interleukin-1 receptor antagonist and interleukin-6 responses.
RESULTS
Women committed marginally fewer errors on the Stroop color-discrepant trials after the typhoid vaccine (M = 0.36, SE = 0.08), compared to placebo (M = 0.54, SE = 0.09, p = .076). Injection type did not predict 2-back accuracy (p = .80) or CPT commission errors (p = .47). Inflammatory cytokine responses were also unrelated to the outcomes of interest (ps>.16).
CONCLUSION
We found no evidence that an acute inflammatory cytokine response provokes response disinhibition - an important facet of impulsivity. In fact, our only marginally non-significant result suggested that women were better able to inhibit their prepotent responses on the Stroop after receiving the typhoid vaccine, compared to placebo. Further experimental tests of the acute inflammatory cytokine response's effect on other aspects of impulsivity are warranted.
LIMITATIONS
The sample was female, primarily White, highly educated cancer survivors, and recruitment was not premised on impulsive traits or diagnosis with an impulsive-related disorder. Also, there are many facets of impulsivity, and this study only measured response inhibition.

Identifiants

pubmed: 37683942
pii: S0165-0327(23)01135-7
doi: 10.1016/j.jad.2023.09.008
pmc: PMC10591975
mid: NIHMS1930315
pii:
doi:

Substances chimiques

Cytokines 0
Typhoid-Paratyphoid Vaccines 0

Types de publication

Randomized Controlled Trial Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-9

Subventions

Organisme : NCI NIH HHS
ID : K05 CA172296
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA016058
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA186251
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001070
Pays : United States

Informations de copyright

Copyright © 2023 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors report no potential conflicts of interest.

Références

Mol Psychiatry. 2020 Jun;25(6):1301-1311
pubmed: 29895893
Brain Behav Immun. 2017 Aug;64:208-219
pubmed: 28089638
Brain Behav Immun Health. 2020 Aug 20;8:100130
pubmed: 34589881
Brain Behav Immun. 2022 Jul;103:1-9
pubmed: 35378230
J Pers. 2008 Dec;76(6):1447-84
pubmed: 19012655
Brain Cogn. 2013 Feb;81(1):82-94
pubmed: 23174432
Mol Psychiatry. 2002;7(5):468-73
pubmed: 12082564
Brain Behav Immun. 2016 Oct;57:255-262
pubmed: 27165989
Brain Behav Immun. 2010 May;24(4):558-63
pubmed: 20043983
Psychosom Med. 2017 Jun;79(5):549-556
pubmed: 28121722
Ann Epidemiol. 2007 Aug;17(8):584-90
pubmed: 17531502
Biometrics. 1986 Mar;42(1):121-30
pubmed: 3719049
J Behav Med. 2012 Dec;35(6):616-23
pubmed: 22190235
Mol Psychiatry. 2021 Jul;26(7):3419-3429
pubmed: 33077852
J Abnorm Child Psychol. 2004 Jun;32(3):295-304
pubmed: 15228178
Neuroimage. 2020 Jan 1;204:116212
pubmed: 31546050
Brain Behav Immun. 2022 May;102:40-41
pubmed: 35143879
Brain Behav Immun. 2023 Jan;107:124-131
pubmed: 36208853
J Neurol Sci. 2012 Dec 15;323(1-2):1-8
pubmed: 22939820
J Clin Epidemiol. 2003 Mar;56(3):221-9
pubmed: 12725876
J Psychiatr Res. 2018 Nov;106:38-42
pubmed: 30261413
Psychopharmacology (Berl). 2016 Sep;233(18):3361-70
pubmed: 27449350
Circulation. 2002 Jun 4;105(22):2600-4
pubmed: 12045164
Neuropsychopharmacology. 2013 Oct;38(11):2179-87
pubmed: 23657438
J Abnorm Psychol. 2017 May;126(4):454-477
pubmed: 28333488
Front Psychol. 2023 Feb 27;14:1127193
pubmed: 36923151
Circulation. 2000 Aug 29;102(9):994-9
pubmed: 10961963
Biol Psychiatry. 2015 Jul 1;78(1):49-57
pubmed: 25526971
Psychoneuroendocrinology. 2013 Oct;38(10):2319-26
pubmed: 23831264
Front Psychol. 2018 Nov 26;9:2208
pubmed: 30534095
Crit Care. 2010;14(3):R81
pubmed: 20444270
Brain Behav Immun. 2021 Aug;96:7-17
pubmed: 33932526
Brain Behav Immun. 2013 May;30:73-9
pubmed: 23333431
Mol Psychiatry. 2021 Aug;26(8):3672-3683
pubmed: 32873895
Neurobiol Learn Mem. 2010 Nov;94(4):561-7
pubmed: 20875866
J Clin Exp Neuropsychol. 2012;34(5):543-60
pubmed: 22380580
Adv Exp Med Biol. 1999;461:75-81
pubmed: 10442168
JAMA Psychiatry. 2014 Feb;71(2):158-65
pubmed: 24352431
Brain Imaging Behav. 2016 Sep;10(3):840-8
pubmed: 26489975
Biol Psychiatry. 2008 Jun 1;63(11):1022-9
pubmed: 18242584
J Affect Disord. 2005 Jan;84(1):93-8
pubmed: 15620390
Psychoneuroendocrinology. 2022 Jul;141:105763
pubmed: 35429698
Front Psychol. 2017 Mar 07;8:352
pubmed: 28326058
Cell Rep. 2020 Mar 24;30(12):4082-4095.e6
pubmed: 32209470
Neuroimage Clin. 2022;35:103053
pubmed: 35617872
Behav Cogn Neurosci Rev. 2005 Dec;4(4):262-81
pubmed: 16585800
Psychol Bull. 2014 Mar;140(2):374-408
pubmed: 24099400
Dev Psychopathol. 2016 Nov;28(4pt1):1177-1208
pubmed: 27739396
Sci Rep. 2019 Mar 20;9(1):4928
pubmed: 30894653
Neuropsychopharmacology. 2002 May;26(5):643-52
pubmed: 11927189
Front Psychol. 2018 Nov 28;9:2306
pubmed: 30546331
Psychiatry Res. 2020 Feb;284:112782
pubmed: 31955054
J Affect Disord. 2014 Sep;166:187-92
pubmed: 25012430
J Natl Cancer Inst. 2018 Dec 1;110(12):1311-1327
pubmed: 30403799
Transl Psychiatry. 2018 Sep 10;8(1):189
pubmed: 30202011

Auteurs

Annelise A Madison (AA)

Institute for Behavioral Medicine Research, The Ohio State University College of Medicine, Columbus, OH, United States of America; Department of Psychology, The Ohio State University, Columbus, OH, United States of America. Electronic address: annelise.madison@osumc.edu.

Rebecca Andridge (R)

Institute for Behavioral Medicine Research, The Ohio State University College of Medicine, Columbus, OH, United States of America; Division of Biostatistics, The Ohio State University, Columbus, OH, United States of America.

Megan E Renna (ME)

School of Psychology, University of Southern Mississippi, Hattiesburg, MS, United States of America.

John F Sheridan (JF)

Institute for Behavioral Medicine Research, The Ohio State University College of Medicine, Columbus, OH, United States of America; Division of Biosciences, The Ohio State University College of Dentistry, Columbus, OH, United States of America.

Maryam Lustberg (M)

Yale School of Medicine, New Haven, CT, United States of America.

Bhuvaneswari Ramaswamy (B)

Department of Internal Medicine, The Ohio State University College of Medicine, Columbus, OH, United States of America; Comprehensive Cancer Center, The Ohio State University College of Medicine, Columbus, OH, United States of America.

Robert Wesolowski (R)

Department of Internal Medicine, The Ohio State University College of Medicine, Columbus, OH, United States of America; Comprehensive Cancer Center, The Ohio State University College of Medicine, Columbus, OH, United States of America.

Nicole O Williams (NO)

Department of Internal Medicine, The Ohio State University College of Medicine, Columbus, OH, United States of America; Comprehensive Cancer Center, The Ohio State University College of Medicine, Columbus, OH, United States of America.

Sagar D Sardesai (SD)

Department of Internal Medicine, The Ohio State University College of Medicine, Columbus, OH, United States of America; Comprehensive Cancer Center, The Ohio State University College of Medicine, Columbus, OH, United States of America.

Anne M Noonan (AM)

Department of Internal Medicine, The Ohio State University College of Medicine, Columbus, OH, United States of America; Comprehensive Cancer Center, The Ohio State University College of Medicine, Columbus, OH, United States of America.

Raquel E Reinbolt (RE)

Department of Internal Medicine, The Ohio State University College of Medicine, Columbus, OH, United States of America; Comprehensive Cancer Center, The Ohio State University College of Medicine, Columbus, OH, United States of America.

Mathew A Cherian (MA)

Department of Internal Medicine, The Ohio State University College of Medicine, Columbus, OH, United States of America; Comprehensive Cancer Center, The Ohio State University College of Medicine, Columbus, OH, United States of America.

William B Malarkey (WB)

Institute for Behavioral Medicine Research, The Ohio State University College of Medicine, Columbus, OH, United States of America; Department of Internal Medicine, The Ohio State University College of Medicine, Columbus, OH, United States of America.

Janice K Kiecolt-Glaser (JK)

Institute for Behavioral Medicine Research, The Ohio State University College of Medicine, Columbus, OH, United States of America; Department of Psychiatry and Behavioral Health, The Ohio State University College of Medicine, Columbus, OH, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH